Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


annika.jodicke@ndorms.ox.ac.uk


ORCID ID https://orcid.org/0000-0002-0000-0110


she/her

Annika Jödicke

Dr. sc. ETH

Senior Researcher in Pharmacoepidemiology

Pharmacoepidemiology | Real-World Evidence

My work as a pharmacoepidemiologist is to improve healthcare for patients by using de-identified healthcare data to generate robust and reliable real-world evidence on the utilisation, safety and effectiveness of medicines.

I am a pharmacist by training, and joined the Health Data Sciences Group in 2020 after completing my doctoral training at ETH Zurich, Switzerland.

Several of my projects use data from across Europe, mapped to the OMOP common data model. I have a particular research interest and expertise in geriatric pharmacoepidemiology, vaccine effectiveness research and regulatory pharmacoepidemiology.

My areas of work include conducting causal inference and drug utilisation studies for the national and European regulators (e.g. in the context of DARWIN EU) as well as methodological work to minimize confounding bias in observational studies.

Since May 2025, I am honoured to co-lead with Prof. Prieto-Alhambra the academic side of the Innovative Health Initiative’s GREG project to generate, pilot-test, and disseminate evidence-based guidance for the use of real-world evidence to support regulatory and HTA decision-making.